USE OF INHIBITORS OF TGFB/ACTIVINB SIGNALING PATHWAY FOR THE TREATMENT OF PATIENTS… Application WO-2021047775-A1 World Intellectual Property Organisation (WIPO) 18 Mar 2021
Compositions and methods for treating medulloblastoma Grant US-10213449-B2 United States of America 26 Feb 2019